¡Ya estamos en ! Descubre más
2.70 USD
-0.15
5.26%
Al cierre Actualizado 19 nov, 10:15 a.m. EST
1 día
-5.26%
5 días
-5.26%
1 mes
-45.01%
3 meses
-45.01%
6 meses
-45.01%
En lo que va del año
-45.01%
1 año
-45.01%
5 años
-45.01%
10 años
-45.01%
 

Acerca de: Nordicus Partners Corp specializes in developing breakthrough therapeutics for diseases with unmet medical needs. The Company focuses on acquiring and developing drugs from biotech companies in the Nordics, a region known for its scientists, life sciences ecosystem, and drug discoveries and developments. Its current portfolio includes the preclinical biotechnology companies Orocidin A/S, Bio-Convert A/S, and NoviThera ApS. The Company is dedicated to developing breakthrough therapeutics in diseases with unmet medical needs, starting with oral disorders. It operates in the segment focused on developing medicines supporting oral health.

Noticias

Positivo
Neutral
Negativo
Sentimiento 3 meses
Positivo 0%
Neutral 0%
Negativo 0%

No hemos recibido artículos de noticias recientes sobre NORD.

Gráficos de precios implementados con Lightweight Charts™